Skip to main content
Caplight Logo









Inmagene

Inmagene

Public
San Diego, CaliforniaBiotechhttps://www.inmagenebio.com

Inmagene is now publicly traded

The data on this page reflects Inmagene's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Private Placement

Jul 25, 2025

Est. Valuation at Exit

$347.22M

Total Funding Raised

$216M

Company Overview

Inmagene is a biotechnology company dedicated to developing innovative therapeutics for immunological and inflammatory diseases.

Sector

Biotech

AI Layer

Non-AI

Keywords

non-depleting anti-OX40 monoclonal antibodyimmunological and inflammatory disease therapeuticsatopic dermatitis biologicsIL-17A inhibitor for psoriatic arthritisextended half-life monoclonal antibodyalopecia areata therapeuticsnon-covalent reversible BTK inhibitoranti-IL-36R mAb for generalized pustular psoriasisclinical-stage immunology drug developmentbiotech drug in-licensing and co-developmentclinical-stage biotechnology company

Inmagene Comparables

Compare Inmagene with similar companies based on industry and business-model similarity.

Inmagene comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Elemental Biologics
48%

Inmagene Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private PlacementJul 25, 2025
Series CJun 1, 2021
Series BNov 9, 2020
Series AFeb 1, 2020

Inmagene Investors

Notable investors and investment history

Inmagene investors
InvestorRounds
HighLight CapitalSeries C
SCVCSeries B
Omega FundsPrivate Placement
Highlight CapitalSeries C
Jiangsu Honghui Equity Investment ManagementSeries C
Triwise CapitalSeries C
Blue Owl CapitalPrivate Placement

Inmagene Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Inmagene Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersSan Diego, California
Year Founded2019
Last FundingJul 25, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?